Lataa...
A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing
An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease, has infected over 290,000 people since the end of 2019, killed over 12,000, and caused worldwide social and economic disruption(1,2). There are currently no antiviral drugs with proven efficacy nor...
Tallennettuna:
Julkaisussa: | bioRxiv |
---|---|
Päätekijät: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
Cold Spring Harbor Laboratory
2020
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7239059/ https://ncbi.nlm.nih.gov/pubmed/32511329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.03.22.002386 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|